|
Program in Outcomes Research
The Program in Outcomes Research, led by Dr. Linda S. Elting,
Associate Professor of Health Services Research, incorporates the following research areas:
- Epidemiologic studies of treatment outcomes and care strategies
including pathway-based care and guideline-based care
using data from large, representative populations
- Cost of illness studies
conducted alongside epidemiological studies to develop clinical models of resources used and costs accrued during cancer treatments
- Population-based studies from large national databases
used to test the generality of models
- Epidemiological and costa data are used to develop clinical prediction rules
which are then integrated into standard care in the insitution
Current projects include the following:
- Risk and outcomes of oral and gastrointestinal muscositis
- A clinical model of the cost of bladder cancer
- Epidemiology of chemotherapy-induced thrombocytopenia
- Cost of chemotherapy-induced thrombocytopenia
- Risk, outcomes, and cost of deep venous thrombosis in patients with cancer
- Cost effectiveness of Dalteparin compared to unfractionated heparin in cancer patients with deep venous thrombosis
- The Bleeding Risk Index: A clinical prediction rule to guide prophylaxis during chemotherapy-induced thrombocytopenia
- The Anticoagulation Safety Index: A tool for selecting low-risk cancer patients for
outpatient management of anticoagulation
|